The state of national electronic prescription systems in the EU in 2018 with special consideration given to interoperability issues
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F20%3A10417101" target="_blank" >RIV/00216208:11110/20:10417101 - isvavai.cz</a>
Alternative codes found
RIV/68407700:21460/20:00341541 RIV/00064165:_____/20:10417101
Result on the web
<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=rktkYnrFHV" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=rktkYnrFHV</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.ijmedinf.2020.104205" target="_blank" >10.1016/j.ijmedinf.2020.104205</a>
Alternative languages
Result language
angličtina
Original language name
The state of national electronic prescription systems in the EU in 2018 with special consideration given to interoperability issues
Original language description
Introduction: The electronic prescribing system (EPS) is now widely used in the USA and largely also in EU member countries. Nevertheless, comparisons of different EPS are very scarce. Whilst the EU strives for cross-border interoperability in healthcare, the aim of this study is to provide a contemporary account of the state of national EPS in such countries. Methods: For the sake of consistency the state of each of the EPS as of the end of 2018 was researched using an e-mail questionnaire. Respondents were chosen from among authors who have previously published studies on electronic prescriptions. Results: Data on EPS was gathered from 23 out of the 28 EU member states. In 2018 EPS was in daily use in 19 EU states, and one further country had a pilot project, whereas the remaining 3 were only at the planning stage. Most of the EPS do not differ significantly in basic design, however authentication procedures vary substantially. Discussion: There is a significant increase in EPS usage in EU countries as compared with previous studies. Cross-border interoperability in the EU is still limited, and further advancement might be hampered by differences in authentication procedures. Conclusion: Although it was not possible to acquire data from all the EU countries, this study shows the present state of electronic prescription in most of them and demonstrates continuous development in this area.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30502 - Other medical science
Result continuities
Project
—
Continuities
V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Others
Publication year
2020
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
International Journal of Medical Informatics
ISSN
1386-5056
e-ISSN
—
Volume of the periodical
141
Issue of the periodical within the volume
September
Country of publishing house
IE - IRELAND
Number of pages
6
Pages from-to
104205
UT code for WoS article
000579780700030
EID of the result in the Scopus database
2-s2.0-85085545690